Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 7.0B | 6.9B | 7.0B | 6.8B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 2.8B | 2.8B | 2.8B | 2.8B |
| Other operating expenses | — | — | — | — |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 2.3B | 2.2B | 2.1B | 2.1B |
| Tax provision | 472M | 443M | 438M | 350M |
| Net income | 1.8B | 1.7B | 1.7B | 1.7B |
| Basic EPS | 1.1 | 1.0 | 1.0 | 1.0 |
| Diluted EPS | 1.1 | 1.0 | 1.0 | 1.0 |
| Basic average shares | 1.6B | 1.6B | 1.6B | 1.6B |
| Diluted average shares | 1.6B | 1.6B | 1.6B | 1.6B |
| EBITDA | — | — | — | — |
| Net income from continuing op. | 1.8B | 1.7B | 1.7B | 1.7B |
| Minority interests | -6M | -7M | -7M | -8M |
| Preferred stock dividends | 12M | 11M | 10M | 10M |